Skip to main content
Download PDF

Oxidative stress and inflammation cause auditory system damage via glial cell activation and dysregulated expression of gap junction proteins in an experimental model of styrene-induced oto/neurotoxicity

Journal of Neuroinflammation volume 21, Article number: 4 (2024) Cite this article

Abstract

Background

Redox imbalance and inflammation have been proposed as the principal mechanisms of damage in the auditory system, resulting in functional alterations and hearing loss. Microglia and astrocytes play a crucial role in mediating oxidative/inflammatory injury in the central nervous system; however, the role of glial cells in the auditory damage is still elusive.

Objectives

Here we investigated glial-mediated responses to toxic injury in peripheral and central structures of the auditory pathway, i.e., the cochlea and the auditory cortex (ACx), in rats exposed to styrene, a volatile compound with well-known oto/neurotoxic properties.

Methods

Male adult Wistar rats were treated with styrene (400 mg/kg daily for 3 weeks, 5/days a week). Electrophysiological, morphological, immunofluorescence and molecular analyses were performed in both the cochlea and the ACx to evaluate the mechanisms underlying styrene-induced oto/neurotoxicity in the auditory system.

Results

We showed that the oto/neurotoxic insult induced by styrene increases oxidative stress in both cochlea and ACx. This was associated with macrophages and glial cell activation, increased expression of inflammatory markers (i.e., pro-inflammatory cytokines and chemokine receptors) and alterations in connexin (Cxs) and pannexin (Panx) expression, likely responsible for dysregulation of the microglia/astrocyte network. Specifically, we found downregulation of Cx26 and Cx30 in the cochlea, and high level of Cx43 and Panx1 in the ACx.

Conclusions

Collectively, our results provide novel evidence on the role of immune and glial cell activation in the oxidative/inflammatory damage induced by styrene in the auditory system at both peripheral and central levels, also involving alterations of gap junction networks. Our data suggest that targeting glial cells and connexin/pannexin expression might be useful to attenuate oxidative/inflammatory damage in the auditory system.

Introduction

Hearing loss induced by the exposure to environmental factors, such as noise or ototoxic drugs, is primarily due to permanent alterations occurring in peripheral and central structures of the auditory pathway [1]. Indeed, hearing loss is associated with cochlear damage to hair cells, afferent neurons and synapses [2, 3] along with short- and long-term detrimental consequences in central auditory structures [4,5,6], with altered basal synaptic transmission and decreased spine density in the auditory cortex (ACx) [7,8,9,10]. Recent findings supported the idea that the unbalance of cellular redox status and inflammation are key mechanisms of cochlear damage. Indeed, in animal models of acquired hearing loss caused by noise exposure or ototoxic drug administration, an increase of reactive oxygen species (ROS), together with an up-regulation of inflammatory mediators have been observed in the cochlea [11,12,13], as well as in brain regions involved in the auditory perception [10, 14].

Dysfunction of glial cells, including astrocytes, oligodendrocytes, and microglia in the central nervous system (CNS), and Schwann cells or satellite cells in the peripheral nervous system (PNS) are strongly involved in damaging mechanisms depending on oxidative stress and inflammation [15,16,17,18,19].

Astrocytes play a crucial role in brain homeostasis, contributing to many functions, including blood–brain barrier maintenance, neurotransmitter cycling, metabolic and synaptic support [20,21,22]. Similarly, microglia, the resident innate immune cells in the CNS [23, 24], regulates several brain functions, such as synaptic plasticity and synaptogenesis, and shapes neuronal circuits during development [25, 26], including auditory brainstem pathways [27], and in post-natal life [28]. Among microglia general markers, ionized calcium-binding adapter molecule 1 (IBA-1), cluster of differentiation receptors, such as CD68, and fractalkine receptor (CX3CR1) are the most widely used, although expressed also in macrophages [20, 21, 29,30,31]. Whereas, largely specific microglia markers include transmembrane protein 119 (TMEM119) and purinergic receptor P2YR12 [29, 30].

Macrophages are phagocytic cells, considered the major overseers of the immune system, regulating tissue homeostasis and inflammatory responses [32,33,34]. They are generally classified in tissue-resident macrophages, responsible for tissue repair, homeostasis, and inhibition of inflammation [35, 36], and monocytes, recruited from the bone-marrow following an insult, promoting the inflammatory response [36,37,38]. Thus, in the auditory system, macrophages have been found distributed in both the peripheral organ, the cochlea (macrophages and perivascular macrophage-like melanocyte) and in the CNS (microglia and perivascular macrophages in the cerebral cortex) [38].

Different from microglia, arising from erythro-myeloid precursors in the yolk sac and, during early stages of embryonic development, migrating to the CNS [39, 40], macrophages are derived from monocytes, which originate from bone-marrow hematopoietic stem cells [41]. On a functional point of view, macrophages and microglia are both plastic, adapting their phenotype to the local tissue micro-environment by changing their morphology, abundance, and distribution in response to insults [32, 33, 38, 42, 43].

Following an injury, glial cells start modulating the production of reactive oxygen and nitrogen species. Indeed, microglia is involved in increased ROS generation in the CNS [44,45,46] and both microglia and astrocytes can modulate inflammatory responses through cytokines, chemokines, and oxidative stress markers [47, 48]. In this view, several studies underlined the role of gap junctions (GJCs), hemichannels (HCs) and pannexons in affecting glial cell function and dysfunction [49,50,51,52,53]. Microglial and astrocyte activation is a complex and dynamic process, based on molecular signaling pathways occurring through opening GJCs, HCs and pannexin (Panx) channels [52, 54, 55]. On the other hand, activated microglia affect connexin expression and GJC and HC functional activity in astrocytes [56,57,58,59,60,61].

Studies performed in different animal models reported persistent macrophages activation in the cochlea and in the auditory nuclei of brainstem, specifically the cochlear nucleus, after auditory deprivation caused by cochlear deafferentation [62,63,64,65]. However, although the contribution of microglia and astrocytes to neuroinflammatory damage has been documented in several CNS disorders, less is known about their role in the auditory system. Thus, we studied immune and glial cell responses in the auditory peripheral organ (i.e., the cochlea) and in the ACx using an experimental model of oto/neurotoxic damage caused by the administration of styrene, a volatile organic solvent with well-documented ototoxic effects at occupational level [66,67,68,69].

Here, we report that macrophages activation in the cochlea and glial cell response in the ACx play a critical role in the oxidative/inflammatory damage of the auditory system, also involving altered expression of connexins and pannexins in cochlear and brain regions.

Materials and methods

Animals

In our experimental plan, we used n = 35 male adult Wistar rats (2–3 months of age) with normal Preyer’s reflex, randomly assigned to three experimental groups: (1) control animals (“Ctrl” group; n = 14); (2) animals treated with styrene by oral gavage (“Styrene” group; n = 14) and (3) control animals that underwent oral gavage of olive oil (“Ctrl-gavage” group; n = 7). Rats were housed two per cage with free access to food (Mucedola 4RF21, Italy) and water. Housing environment was temperature (22–23 °C) and humidity (60% ± 5%) controlled, with a 12-h light/dark cycle. All efforts were made to minimize animal suffering and number, in agreement with the European Community Council Directive of 24 November 1986(86/609/EEC). All procedures were performed in accordance with the Laboratory of Animal Care and Use Committee of the Catholic University, School of Medicine of Rome and were approved by the Italian Department of Health (Ministero della Salute, Prot. 1F295.116 and Prot. 1F295.117). A schematic representation of the experimental plan is reported in Fig. 1. A list of abbreviations in the whole text is reported in the Additional file 1: Table S1. Experiments were performed according to the Arrive guidelines (Additional file 2).

Fig. 1
figure 1

Workflow of the experimental design. Male adult Wistar rats were randomly assigned at the beginning of the study to three experimental groups: “Ctrl”, “Styrene” and “Ctrl-gavage” groups. Baseline hearing thresholds were evaluated in all animals the day (D) before starting styrene treatment (D-1) by recording auditory brainstem responses (ABR). Animals of Styrene group underwent oral gavage treatment with styrene (400 mg/kg) for 3 weeks (from D0 to D21), once daily, 5 days a week. At the same time, Ctrl-gavage group underwent vehicle delivery (olive oil). At the end of the treatment (D21), after ABR recordings, animals were scarified and tissues, both cochlea and auditory cortex (ACx), were collected to perform experimental analyses. fEPSP: field excitatory postsynaptic potentials; WB: western blot; IF: immunofluorescence; Golgi: Golgi–Cox staining

Full size image

Oto/neurotoxic insult: styrene administration

To damage the auditory system, we used styrene administration, a well-known oto/neurotoxic volatile compound. Indeed, styrene exposure has been previously shown to cause cochlear damage and hearing loss [66, 67]. Thus, styrene (styrene > 99%, Sigma Corporation, product id: S4972) was dissolved in olive oil, as reported in previous published protocols [66, 67] and administered by oral gavage for 21 days, following a dosage and time schedule of treatment previously used (400 mg/kg daily for 3 weeks, 5/days a week) [66, 67, 69]. At the end of styrene treatment, animals were sacrificed, brain and cochlear samples were collected to perform all experimental evaluations.

Auditory brainstem responses (ABR)

To evaluate cochlear damage and hearing loss we measured ABRs, as described previously [8]. Briefly, using active, reference and ground needle electrodes (inserted subcutaneously in tested pinna, vertex, and contralateral pinna, respectively), we recorded auditory bioelectrical potentials in animals mildly anesthetized (ketamine, 35 mg/kg and medetomidine-domitor, 0.25 mg/kg) subjected to acoustic click stimuli at decreasing intensity levels (from 100 to 10 dB). Data were collected and analyzed using a TDT System 3 (Tucker Davis Technologies, Alachua, FL, United States).

The lower stimulus intensity able to evoke a repeatable ABR waveform was considered as the auditory threshold. We also measured the wave II amplitude–intensity (A–I) curve from ABR recordings as previously reported [7, 70].

Ex vivo electrophysiology

We performed field recordings on coronal slices (400 μm-thick) containing the ACx as previously described [8,9,10]. FEPSPs were evoked in pyramidal neurons of layer II/III of the ACx by stimulating local connections using a concentric bipolar tungsten electrode (FHC Inc., Bowdoin, ME, USA) connected to a stimulator. I/O curves were obtained by afferent fiber stimulation at intensities ranging from 0 to 300 µA (in increments of 50 µA; stimulus rate of 1 pulse every 20 s).

Tissue section preparation and immunofluorescence staining

Immunofluorescence experiments were performed in both cochlear and ACx samples.

In cochlear specimens, we performed immunofluorescence analyses in both cryosections (obtained as described in [66]) and in surface preparations of the basilar membrane with the organ of Corti, obtained through cochlear microdissection as described previously [7, 8].

To perform analyses in the ACx we used 40-μm-thick coronal brain cryosections, collected from 2.18 mm to 3.4 mm posterior to bregma [71], containing the ACx [8, 10]. Cochlear surface preparations/sections or brain sections containing ACx were incubated with a blocking solution (containing 1% BSA, 0.5% Triton X-100 and 10% normal goat serum in PBS 0.1 M) and then they were incubated overnight at 4 °C with a solution containing primary antibodies against: IBA-1, GFAP, COX-2, CtBP2, NF200, CD68. All specimens were incubated at room temperature (RT) for 2 h with donkey anti-rabbit and/or anti-mouse secondary antibody solution (Alexa Fluor 488 or 546) and DAPI stained to visualize cell nuclei. Detailed information about the antibodies is reported in Table 1.

Table 1 List of reagents and antibodies used
Full size table

To evaluate ROS production in the ACx we used dihydroethidium (DHE) staining as described in [9]. Fluorescent images were acquired using a confocal laser scanning microscope (Nikon Ti-E, Confocal Head A1 MP, Tokyo, Japan) with a 20 × objective lens.

To verify the specificity of fluorescence labeling, control experiments were obtained by omitting the primary antibodies in samples randomly selected (data not shown).

Morphological analyses in the ACx: glial cell morphology and neuronal spine density

To evaluate neuronal dendritic spine density in ACx pyramidal neurons of layer II/III, brains from Styrene and Ctrl animals (n = 3/group) were stained with the Golgi–Cox solution, according to previously published protocol [7,8,9]. Images were collected and analyzed by an Olympus BX63 microscope, equipped with a 100 × objective.

Macrophages, microglial and astrocyte cells were identified by immunofluorescence staining using IBA-1 and GFAP-specific antibodies to analyze cell morphology [72,73,74]. Thus, IBA-1 and GFAP positive-cells in the ACx were visualized with a Zeiss microscope with a motorized stage, connected to Neurolucida 7.5 software (MicroBright-Field). To analyze cell morphology, Sholl analysis was applied [75]. Only cells clearly detectable and displaying intact processes were taken into consideration. We analyzed several structural parameters, including: (1) process length (in µm); (2) the number of branch points (bifurcating nodes); (3) the total number of intersections between process and a shell and (4) average of total surface area in µm2 [76,77,78].

Western immunoblot and dot blot analyses

To obtain semi-quantitative data on protein levels, we performed western blots or dot blots on both cochlear and ACx lysates, obtained from at least 3/animals/group, as previously described [10, 79]. Briefly, total proteins were extracted using ice-cold RIPA buffer according to our previous published protocols [10, 80] and protein lysates (30 μg) were loaded onto Tris–glycine polyacrylamide gels for electrophoretic separation. Proteins were then transferred onto nitrocellulose membranes and, after 1 h with blocking buffer (5% skim milk in TBST), they were incubated overnight at 4 °C with primary antibodies. Membranes were then incubated overnight at 4 °C with a solution containing antibodies against: caspase, cleaved-caspase 3, NF-κB, TNF-α, IL-1β, COX-2, CXCR1, GFAP, CD68, iNOS, Cx43, Cx26, Cx30, Panx1.

For dot blot, 5 μl of cochlear or ACx lysates (5 μg/μl) were spotted into a TBST pre-wetted nitrocellulose membrane as described previously [9]. Antibodies against 3-nitrotyrosine (3-NT), and 4-hydroxynonenal (4-HNE) were used to evaluate protein tyrosine nitration and lipid peroxidation, respectively.

After incubation with primary antibody solution, western blot or dot blot membranes were washed in TBST and then incubated with HRP-conjugated mouse or rabbit secondary antibodies for 1 h at RT. Primary antibodies anti-GAPDH, or anti-β-tubulin mouse monoclonal antibody were used to make sure of equal protein loading. Detailed information about all antibodies used is reported in Table 1.

The quantification of protein levels was performed using UVItec Cambridge Alliance system. Experiments were performed in triplicate.

Statistical analysis

Sample size was determined after a power analysis performed to obtain a statistical power of 80% at an α level of 0.05. Statistical analyses were performed in a blind manner. The statistical tests used (two-way ANOVA or Student’s t test) are specified in the main text and in figure legends. Tukey’s Post-hoc was used for multiple comparisons (SigmaPlot 14.0 or Statistica, Statsoft). The level of significance was set at 0.05. Results are presented as mean ± SEM.

Results

Styrene exposure causes functional and morphological damage in the auditory system

To determine the role of microglia and astrocyte activation in the auditory system damage we used an experimental model of oto/neurotoxic injury caused by styrene administration. Figure 1 summarizes all experimental procedures and a timeline of the experimental plan. We previously reported that styrene exposure impinges on cochlear function, leading to hearing loss and diminished neuronal transmission times in primary afferent fibres [66, 67]. Here, we first confirmed our previous findings, showing that styrene administration induced an increase of auditory threshold of about 25 dB in click responses at the end of treatment (day 21, Fig. 2A; n = 14 rats for each group; Student’s t test, p < 0.001). No significant differences were found between Ctrl and Ctrl-gavage in ABR values (data not shown), indicating no alteration of auditory function. The A–I curve derived from ABR wave II amplitude, for click responses at different intensity levels (dB), showed a significant decrease of amplitude responses in Styrene animals, compared to Ctrl group (Fig. 2B; n = 14 rats for each group; Student’s t test, p < 0.001). This functional injury was also associated with cochlear synaptic damage. Indeed, our immunofluorescence analysis on surface preparations of the organ of Corti showed fewer synaptic ribbons (Fig. 2C, D) in both outer (OHCs) and inner (IHCs) hair cells, associated with reduced number of primary afferent fibres in styrene-treated animals compared to controls (compare Fig. 2C with Fig. 2D).

Fig. 2
figure 2

Functional and synaptic damage caused by styrene exposure in the cochlea. A Graph show mean ABR threshold values (means ± SEM) for click stimuli indicating a hearing loss (of about 25 dB) after styrene treatment (n = 14 rats for each group; Student’s t test, p < 0.001). B Amplitude–intensity curves obtained by measuring amplitude of wave II of ABR click responses with decreased intensity (means ± SEM). Styrene treatment induces a significant decrease of wave II amplitude, confirming neuronal damage. C, D Images of surface preparations of the organ of Corti from control (C) and styrene-treated animals (D). The one row of inner hair cells (IHCs) and three rows of outer hair cells (OHCs) are stained with DAPI to visualize cell nuclei. CtBP2 puncta (red staining) indicate pre-synaptic contacts between the hair cells and afferent nerve fibers, stained with NF200 (in green). Scale bar: 20 μm. Significant differences between groups are indicate by asterisks (***p < 0.001)

Full size image

Moving to the ACx, we studied synaptic responses after focal stimulation of ACx layer II/III neurons in slices from Styrene and Ctrl animals. Comparing the I/O curves, we observed that fEPSPs were significantly lower in rats exposed to styrene compared to controls (Fig. 3A; n = 17 slices from 4 Styrene and n = 16 slices from 4 Ctrl rats; two-way ANOVA, Tukey’s post-hoc test, F(1,217) = 28,473, p < 0.001), indicating that basal synaptic transmission in ACx was altered by the toxic insult. At morphological level, we performed spine density analysis in ACx layer II/III neurons. We found a significant decrease of spine density in both neuronal apical and basal dendrites of styrene-treated animals with respect to controls (Fig. 3B–F, Student’s t test, p < 0.0001; Ctrl n = 40 segments from n = 3 rats/group and Styrene n = 30 segments analysed from n = 3 rats/group), indicating that the auditory toxic insult affected glutamatergic synapses in the ACx. Thus, at molecular level, we focused on the AMPA receptor phosphorylation (AMPAR) at Ser845 (pGluA1Ser845), which is known to be crucial in receptor function, trafficking, and conductance, also in experimental models of experience-dependent synaptic plasticity [81,82,83,84]. Western blot analyses on ACx lysates revealed a significant low level of pGluA1Ser845 in styrene-treated animals (Fig. 3G, n = 3 animals/group; Student’s t test, p = 0.022), confirming altered glutamatergic transmission. Finally, we found a significant high level of cleaved caspase-3 in ACx lysates of styrene-treated animals compared to controls, indicating the activation of apoptotic pathway (Fig. 3H, n = 3 animals/group; Student’s t test, p = 0.0004).

Fig. 3
figure 3

Morphological and functional damage induced by the oto/neurotoxic insult in the auditory cortex (ACx). A Graph shows results of field excitatory post-synaptic potential (fEPSP) amplitude measured following stimulation of afferent fibers in ACx layer II/III at increasing intensities. Statistical analysis by two-way ANOVA followed by Tukey’s post-hoc revealed significant differences between groups (p < 0.001; n = 17 slices from 4 Styrene and n = 16 slices from 4 Ctrl rats). B–E Representative images of Golgi-stained segments from apical (B, D) and basal dendrites (C, E) of pyramidal neurons of layers II/III in Ctrl and Styrene groups. Scale bar: 10 μm. F Bar graphs showing values of spine density in apical and basal dendrites of neurons of layer II/III of the ACx in the experimental groups (n = at least 30 segments from 30 different neurons were analyzed from three animals/groups; two-way ANOVA, apical dendrites p < 0.0001, basal dendrites p < 0.0001). G, H Images of western immunoblot indicating lower pGluA1Ser845 (G) and higher cleaved caspase-3 (H) levels in the ACx of styrene-treated rats compared to controls. Histograms show densitometric analyses in all samples normalized to total protein amount (GluA1 and GAPDH/Caspase-3) (n = 3 animals for each group; Student’s t test, pGluA1 p = 0.022; Caspase-3 p = 0.0004). Data are expressed as mean ± SEM. Asterisks indicate statistical significance (*p < 0.05; ***p < 0.001)

Full size image

Oxidative stress and neuroinflammation in the cochlea and auditory cortex of styrene-treated animals

Previous studies, including ours, demonstrated redox imbalance associated with inflammation in the cochlea following styrene exposure [66, 67, 85]. Here, we extended our analyses to the whole auditory system by also studying central auditory brain structures, i.e., the ACx. First, we performed dot blot analyses showing high level of 4-HNE and 3-NT in Styrene cochlear samples (Fig. 4A, B, 3-NT n = 3 animals/group; Student’s t test, p = 0.013; 4-HNE n = 4 animals/group; Student’s t test, p = 0.006), thus indicating high level of protein tyrosine nitration and lipid peroxidation in animals treated with the toxic compound. Moreover, we studied nitric oxide (NO) production by analysing the level of inducible NOS (iNOS) that was significantly higher in cochlear samples of animals treated with styrene (Fig. 4C, n = 3 animals/group; Student’s t test, p = 0.029), with respect to controls. These findings confirmed that styrene cochlear injury involves oxidative damage, altering cochlear redox status. We also evaluated the cochlear level of cyclooxygenases-2 (COX-2), usually observed in response to inflammatory stimuli [86], by immunofluorescence and western blot analyses. Our results showed a marked COX-2 fluorescence in styrene-treated animals (Fig. 4E) compared to control specimens (Fig. 4D), specifically in the stria vascularis (Fig. 4d1, e1), the organ of Corti (Fig. 4d2, e2) and SGNs (Fig. 4d3, e3). The COX-2 high level in the cochlea of styrene-treated animals was also confirmed by western blot analyses (Fig. 4F, n = 3 animals/group; Student’s t test, p = 0.001). Finally, we focused on the chemokine receptors CXCR1, considering that it is activated by ROS production [87] and that the increase of inflammatory markers can modulate its transcription [88], and we found a significant high level of CXCR1 in cochlear lysates of styrene-treated animals with respect to controls (Fig. 4G, n = 3 animals/group; Student’s t test, p = 0.0002).

Fig. 4
figure 4

Increased oxidative stress and neuroinflammation in the cochlea after styrene exposure. A, B Representative dot blots showing high protein tyrosine nitration (3-NT, n = 3 rats for each group; Student’s t test, p = 0.013) and lipid peroxidation (4-HNE, n = 4 animals for each group; Student’s t test, p = 0.006) in the cochlea of styrene-treated animals compared to control samples. Ponceau S staining confirmed equal protein loading. C Western blot images showing elevated levels of iNOS, indicating oxidative damage in the cochlea of styrene-treated animals compared to controls (n = 3 animals for each group; Student’s t test, p = 0.029). D, E Representative images of cochlear longitudinal sections showing high magnifications of the lateral wall (LW) with stria vascularis (SV; d1, e1), the organ of Corti (oC; d2, e2) and spiral ganglion neurons (SGNs; d3, e3) stained with COX-2, as a marker of oxidative-inflammatory damage (green fluorescence) and DAPI (blue fluorescence) to label cell nuclei. A marked increase of fluorescence signal was observed in Styrene (E) compared to Control (Ctrl) group (D). Data are representative of three independent experiments from three animals/group. Scale bar: 100 μm in d1; 30 μm in d2 and 50 μm in d3. F, G Western blot bands showing high levels of COX-2 (F) and CXCR1 (G) in Styrene group compared to Ctrl group. Histograms (means ± SEM) show data from densitometric analyses on all samples (COX-2 n = 3 animals for each group; Student’s t test, p = 0.001; CXCR1 n = 3 animals for each group; Student’s t test, p = 0.0002) normalized to GAPDH. Asterisks indicate significant differences between groups (*p < 0.05; **p < 0.01; ***p < 0.001)

Full size image

Interestingly, in the ACx we also observed enhanced ROS amount in styrene-treated animals compared to controls, as shown by DHE assay on coronal brain sections (Fig. 5A, B) and confirmed by semi-quantitative analysis of fluorescence signal (Fig. 5C, n = 3 animals/group; Student’s t test, p < 0.0001). This was associated with high levels of 3-NT and 4-HNE, as shown by dot blot (Fig. 5D, E, 3-NT n = 4 animals/group; Student’s t test, p = 0.003; 4-HNE n = 4 animals/group; Student’s t test, p = 0.016). Western blot analyses of ACx lysates also revealed a significant high level of inflammatory markers, including IL-1β, TNF-α and NFκB, in styrene-treated animals with respect to controls (Fig. 5F, H, IL-1β, n = 3 animals/group; Student’s t test, p = 0.024; TNF-α n = 4 animals/group; Student’s t test, p = 0.001; NFκB n = 4 animals/group; Student’s t test, p = 0.0005). According to what observed in the cochlea, we found a significant high COX-2 protein level also in the ACx of Styrene group compared to Ctrl (Fig. 5G, n = 3 animals/group; Student’s t test, p = 0.03).

Fig. 5
figure 5

Neurotoxic damage involves oxidative stress and neuroinflammation in the auditory cortex. A, B DHE staining in brain coronal sections showing the auditory cortex (ACx) of control (A, Ctrl) and styrene-treated animals (B). C Histograms showing fluorescence intensity signal quantification. Data are expressed as mean ± SEM and are representative of three independent experiments from three animals/group. Scale bar: 100 μm. D, E Dot blots indicating an increase of protein tyrosine nitration (3-NT) and lipid peroxidation (4-HNE) in styrene-treated animals with respect to controls. d1, e1 Histograms (means ± SEM) show semi-quantitative analyses of optical density (3-NT, n = 4 animals for each group; Student’s t test, p = 0.003; 4-HNE, n = 4 animals for each group; Student’s t test, p = 0.016). Equal protein loading was assessed by Ponceau S staining. F–H Representative western blots showing high levels of inflammatory markers, such as IL-1β (F), COX-2 (G), NFκB and TNF-α (H). f1–h2 Graphs show the results of densitometric analyses on all samples for IL-1β (f1, n = 3 animals for each group; Student’s t test, p = 0.024), COX-2 (g1, n = 3 animals for each group; Student’s t test, p = 0.03), NFκB (h1, n = 4 animals for each group; Student’s t test, p = 0.0005) and TNF-α (h2, n = 4 animals for each group; Student’s t test, p = 0.001) normalized to the GAPDH or β-tubulin levels. Asterisks refers to significant differences between groups (*p < 0.05; **p < 0.01; ***p < 0.001)

Full size image

Collectively, these data demonstrate that the combined detrimental effect of oxidative stress and inflammation impinges on the auditory system of styrene-exposed rats, affecting both peripheral (cochlea) and central (ACx) regions.

Macrophages activation in the cochlea

Our immunofluorescence analyses in cochlear cryosection showed an increase of IBA-1 positive cells in samples of styrene-treated animals compared to controls (Fig. 6A–F), specifically in the lateral wall with stria vascularis (Fig. 6B, b1, E; Student’s t test, p = 0.0001) and SGNs (Fig. 6D, d1, F; Student’s t test, p = 0.002). Moreover, we found increased levels of the phagocytic marker CD68 in cochlear lysates of styrene-treated animals with respect to controls (Fig. 6G, n = 4 cochlea/group; Student’s t test, p = 0.03). Considering that supporting cells in the cochlear sensory epithelium, including Schwann cells and satellite cells, express GFAP [89], we also evaluated its expression in cochlear lysates, and we found a significant elevation of GFAP levels in styrene-treated animals, with respect to controls (Fig. 6H, n = 4 cochleae/group; Student’s t test, p = 0.009). Collectively, this data documented macrophages activation in the cochlea after styrene insult.

Fig. 6
figure 6

Macrophages play a role in ototoxic damage induced by styrene. A–D Images of cochlear sections showing high magnifications of the lateral wall (LW) with stria vascularis (SV; A, B) and spiral ganglion neurons (SGNs; C, D) stained with IBA-1, (green fluorescence) and DAPI (blue fluorescence). High magnifications show a strong IBA-1 fluorescence in the LW (b1) and SGNs (d1) in styrene cochlear samples. Scale bar: A, B 100 μm; C, D 50 μm. E, F Histograms showing IBA1-positive cell density in the LW (E) and in SGNs (F). Data are expressed as mean ± SEM and are representative of three independent experiments from three animals/group. G, H Representative western blots showing high levels of CD68 and GFAP in cochlear lysates in Styrene compared to Ctrl groups. Histograms (means ± SEM) show the optical density values (CD68 n = 3 cochleae for each group, p = 0.03; Student’s t test; GFAP n = 4 cochlea for each group; Student’s t test, p = 0.009) normalized to the corresponding total protein amount (GAPDH). Asterisks show statistical significance (*p < 0.05; **p < 0.01; ***p < 0.001)

Full size image

Microglia and astrocytes characterization in the ACx

In the ACx, we found an increase of CD68 expression in IBA-1 positive cells indicating macrophages/microglia activation following styrene toxic insult (Fig. 7A, B). Considering that functional alterations in microglia are usually associated with changes in their morphology [90], we further investigated the effects of the styrene administration on the structural features of glial cells. Specifically, microglia cells of styrene-treated animals showed shorter process length (Fig. 7C, Student’s t test, p = 0.002), diminished total area (Fig. 7D, Student’s t test, p = 0.017), reduced number of bifurcating nodes (Fig. 7E, Student’s t test, p = 0.02) and decreased number of intersections (Fig. 7F, Student’s t test, p = 0.007). Moreover, the increase of GFAP immunoreactivity in styrene-treated animals (Fig. 8A, B) was associated with morphological changes in astrocytes, with increased process length (Fig. 8C, Student’s t test, p = 0.03) and an increase of total area (Fig. 8D, Student’s t test, p = 0.03), number of bifurcating nodes (Fig. 8E, Student’s t test, p = 0.002) and number of intersections (Fig. 8F, Student’s t test, p = 0.03) in styrene-treated animals compared to controls.

Fig. 7
figure 7

Altered microglia morphology in the auditory cortex of styrene-treated animals. A, B Representative images of brain coronal sections showing IBA-1 (green fluorescence) and CD68 (red fluorescence), expression in the auditory cortex (ACx) of control (A, Ctrl) and styrene-treated animals (B). Arrows in B indicate the co-localization of CD68 in IBA-positive cells. Scale bar: 50 μm. a1, b1 Schematic representation of camera lucida drawings of single cell from control (a1) and styrene-treated animal (b1) analyzed with Sholl analysis. C–F Bar graphs (mean ± SEM) indicate differences in dendritic length (C, Student’s t test, p = 0.002), average of total surface area (D, Student’s t test, p = 0.017), total number of bifurcating nodes (E, Student’s t test, p = 0.02) and total number of dendritic intersections (F, Student’s t test, p = 0.007) of IBA1-positive cells in both experimental groups. Asterisks indicate significant comparisons (*p < 0.05; **p < 0.01)

Full size image
Fig. 8
figure 8

Neurotoxic insult causes astrogliosis in the ACx. A, B Representative images of brain coronal sections stained with GFAP (red fluorescence) showing the auditory cortex (ACx) of control (A, Ctrl) and styrene treated animals (B). Scale bar: 50 μm. a1, b1 Schematic representation of a camera lucida drawing of a single GFAP-positive astrocyte from control (a1) and styrene-treated animal (b1) analyzed with Sholl analysis. C–F Bar graphs (mean ± SEM) indicate differences in total dendritic length (C, Student’s t test, p = 0.03), average of total surface area (D, Student’s t test, p = 0.03), number of bifurcating nodes (E, Student’s t test, p = 0.002) and number of total intersections (F, Student’s t test, p = 0.02) of astrocytes marked with GFAP in both experimental groups. Asterisks indicate significant differences between groups (**p < 0.01; ***p < 0.001)

Full size image

Collectively, these data demonstrate that styrene toxic insult induced structural changes in glial cells, leading to a shift from “resting” to “active” morphology.

Altered connexin and pannexin expression contributes to glial cell activation and to the oxidative/inflammatory damage

Finally, we wondered if pannexons and gap junctions participate in the glial cell alterations reported above. In the ACx, we focused on Cx43, the major connexin isoform in the brain, and on Panx1. Our results showed a significant higher level of both Cx43 and Panx1 in brain samples of styrene-treated animals (Fig. 9A, B, Cx43 n = 3 animals/group; Student’s t test, p = 0.03; Panx1 n = 3 animals/group; Student’s t test, p = 0.0001). In the cochlea, we focused on Cx30 and Cx26, that are known to play a crucial role in cochlear physiology [91, 92]. Differently from what observed in the brain, we found a strong reduction of Cx30 and Cx26 in the cochlea of styrene-treated animals, compared with control specimens (Fig. 9C, D, Cx26: n = 3 samples/group; Student’s t test, p = 0.04; Cx30: n = 3 samples/group; Student’s t test, p = 0.01). On the other hand, the expression of Panx1 was similar comparing Ctrl vs Styrene group (Fig. 9E, n = 3 samples/group; Student’s t test, p > 0.05).

Fig. 9
figure 9

Different alterations of connexin and pannexin expression in the cochlea and auditory cortex after the oto/neurotoxic insult. A, B Representative bands of western blot showing high levels of Cx43 and Panx1 in the auditory cortex (ACx) of styrene-treated animals compared to controls. Bar graphs show optical density values in all samples (Cx43 n = 3 animals/group; Student’s t test, p = 0.03; Panx1 n = 3 animals/group; Student’s t test, p = 0.0001) normalized to the corresponding total protein levels (GAPDH). C–E Western blots showing expression levels of Cx26, Cx30 and Panx1 in cochlear lysates of styrene-treated animals compared to controls. Bar graphs show densitometric analyses (Cx26, n = 3 animals/group; Student’s t test, p = 0.04; Cx30, n = 3 animals/group; Student’s t test, p = 0.017; Panx1, n = 3 animals/group; Student’s t test, p > 0.05). Asterisks indicate significant differences between groups (*p < 0.05; ***p < 0.001)

Full size image

Discussion

In this study, we explored the role of glial cells in the auditory system damage using a model of oto/neurotoxicity induced by styrene exposure. Indeed, even though several reports underlined the crucial role of microglia and astrocytes in mediating oxidative/inflammatory damage in brain disorders, including neurodegenerative diseases, the role of glial cells in the auditory system injury is still elusive. Here, we report that microglia and astrocytes mediate oxidative/inflammatory damage in the auditory system. Specifically, we demonstrated that the oto/neurotoxic insult induced by styrene increased oxidative stress and inflammation in both the cochlea and the ACx via macrophages and glial cell activation, involving altered expression of connexins and pannexin, probably dysregulating microglia/astrocyte networks.

First, we characterized our model of oto/neurotoxicity by assessing the detrimental effects of styrene exposure on both cochlea and ACx. In agreement with literature data [66, 67, 69], we found that styrene exposure induced a marked ototoxicity, as documented by the increase of auditory threshold associated with structural alterations in the cochlear sensory-neuronal compartment, such as decreased number of hair cell/neuronal afferent fiber contacts and decreased amplitude of ABR wave II, reflecting diminished number of neurons firing in the cochlear nuclei [70]. Interestingly, we also observed functional, morphological, and molecular alterations in the ACx of styrene-treated animals, with decreased basal synaptic transmission in the horizontal connections of auditory neurons, decreased number of dendritic spines and alterations in post-synaptic proteins, such as GluA1 phosphorylation. Specifically, phosphorylation at Ser845 GluA1 subunit is known to stabilize AMPA receptor at dendrites [93] and it is considered critical for sensory deprivation-induced homeostatic synaptic response and for experience-dependent synaptic plasticity [83, 84].

Several studies support the existence of a strong association between oxidative stress and inflammation in cochlear damage due to exogenous factors, including ototoxic injury. Indeed, when redox balance is altered, inflammatory response increases, triggering a vicious circle with a consequent rise of both ROS and pro-inflammatory cytokines [94,95,96,97]. The increase of oxidative stress observed not only in the cochlea but also in the ACx, confirms that the mechanism of action of styrene primarily involves mitochondrial damage and oxidative stress [98,99,100,101].

Looking for a cellular mechanism linking oxidative stress and inflammation, we focused on glial cells. Our analyses showed a high IBA-1 positive cells and GFAP level in the cochlea, paralleled to elevated of oxidative stress and inflammatory marker amount. Specifically, macrophages in the lateral wall and SGNs were activated, as revealed by the increased number of amoeboid cells with a pro-inflammatory and phagocytic phenotype. These findings agree with macrophages activation observed in different experimental models of cochlear damage, such as aminoglycoside ototoxicity, age-related hearing loss and noise exposure [38, 102,103,104,105,106]. Our western blot analyses also revelated high CD68 protein levels. Whether this was related to increased number of cells expressing CD68 in the cochlea, to inhibition of CD68 degradation, or to an increase in CD68 protein synthesis at the single-cell level, needs further investigations.

Activated glia cells can release several neurotoxic markers [107,108,109], including NO. The synthesis of NO is catalyzed by NO synthases (NOS) [110], such as iNOS. The latter is expressed in macrophages, microglia, astrocytes, and other cell types in response to inflammatory stimuli, LPS and cytokines [110, 111], and it has been found to be expressed by activated microglia [108, 111, 112]. Interestingly, in conjunction with higher protein tyrosine nitration and lipid peroxidation, as markers of oxidative stress, we found a significant high level of iNOS in cochlear lysates of styrene-treated animals. These data are also consistent with the elevated COX-2 level in the same samples, considering that COX-2 inhibitors can reduce iNOS expression in in vitro models of activated microglia [113]. The high level of the main inflammatory markers and of the chemokine receptor CXCR1, can be linked to the activation of glial cells. Indeed, it is known that microglia secrete inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β), IL-6, and chemokines [114,115,116]. This can lead to the activation of microglia NADPH oxidase and to neuronal death, through the formation of peroxynitrite and iNOS production [117]. Moreover, the expression of pro-inflammatory cytokine TNF-α, can increase iNOS [118,119,120], and the chemokine receptor CXCR1 [121] in neuronal cells.

The involvement of microglia and astrocytes was also confirmed by immunofluorescence and morphological analyses on brain sections. Traditionally, the morphology of microglia has been classified in a “resting” state, characterized by highly branched morphology, and an “active” state, in which cells show an amoeboid form with decreased branch complexity [122, 123]. Our morphological analyses in ACx confirmed the presence of morphological changes documenting microglial activation after styrene exposure, including diminished branch length, diminished number of bifurcating nodes, intersections, and surface area. Moreover, the increased expression of CD68 indicates phagocytic activity [124]. Similar to microglia, reactive astrocytes exhibit several molecular and morphological features, including increased GFAP expression [72, 125]. Following an injury, reactive astrocytes increased in number and show altered morphology with hypertrophy of cellular processes [126, 127]. Accordingly, our data reports an increase of astrocytic branching complexity in the ACx of Styrene group, compared to controls.

Finally, considering that pro-inflammatory signaling occurs via gap junctions, hemichannels, and pannexons, favoring the shift between resting and active microglia near the injury site, we looked for connexin and pannexin expression in the cochlea and in ACx after styrene exposure. Interestingly, in the ACx we found an elevated level of Cx43 and Panx1, two proteins playing a crucial role in microglia and astrocyte coupling [51]. Indeed, when microglia become activated, the expression level of connexins, particularly Cx43, increases [49, 128, 129]. In physiological condition, astrocytes are strongly paired via gap junctions, expressing high levels of Cx43 [130]. However, decreased Cx43 amount have been observed in astrocytes cultured with resting microglia [56], whereas increased Cx43 expression was observed following LPS treatment [59]. Moreover, Cx43 and Panx1 functioning is also modulated by several inflammatory/toxic agents, including TNF-α, interferon gamma (IFN-γ) or amyloid-beta protein [129]. Similarly, Cx43 participates to ROS spreading among cells [131]. In addition, increased surface levels of Panx1 and Cx43 correlates with channel opening and microglial activation [132]. Finally, Panx1 channels activity can modulate microglial morphology and microglia/neurons interactions [133].

In the cochlea we studied Panx1 and, among connexins, we focused on the two main connexins playing a crucial role in inner ear physiology, i.e., Cx26 and Cx30 [91, 134]. In contrast to what observed in the brain, we found a downregulation of connexins and no changes in pannexin expression in the cochlea of styrene-treated animals compared to controls. This different pattern of connexin/pannexin modulation in the cochlea and ACx seems to be inconsistent; however, it should be considered the different functional expression of connexins and pannexins in the brain and in the inner ear. Indeed, while Cx43 and Panx1 have been related to microglia activation in the CNS [51], Cx30 and Cx26 are essential for hearing function, given that deletion of the GJB2 and GJB6 genes, encoding for Cx26 and Cx30, respectively, is the main cause of non-syndromic sensorineural hearing loss in the Mediterranean population [135,136,137]. Moreover, in animal models of age-related hearing loss it has been demonstrated that oxidative stress can downregulate cochlear Cx26 and Cx30 expression [138, 139]. On the other hand, decreased Cx26 and Cx30 levels can exacerbate redox imbalance, impairing the endogenous antioxidant enzyme efflux in the cochlear sensory epithelium [92, 140]. Thus, our data seem to be consistent with the increased oxidative stress observed in styrene-treated samples. Notably, we did not find a significant difference in Panx1 cochlear level between styrene-exposed and control animals. However, the role of Panx1 in the cochlea is controversial, with some studies suggesting that altered Panx1 expression can cause hearing loss [141, 142] and others supporting the idea that Panx1 is dispensable for hearing [143, 144].

Conclusions

Collectively, our data indicate that the oto/neurotoxic effects of styrene rely on oxidative/inflammatory damage occurring in both the cochlea and ACx. In both auditory structures activated macrophages, microglia and astrocytes mediate the crosstalk between oxidative stress and inflammation, also via the altered expression of connexins and pannexins. Specifically, in the cochlea the ototoxic effect of styrene induces an increase of oxidative stress with diminished connexin expression (probably exacerbating redox imbalance), macrophages activation and increased inflammation. In the ACx, the neurotoxic insult causes oxidative stress, microglia, and astrocyte activation with increased neuroinflammation and decreased connexin and pannexin expression. This probably causes alterations in microglia/astrocytes coupling, exacerbating neuroinflammation.

Availability of data and materials

The data included in the article are available from the corresponding author.

References

  1. Fetoni AR, Troiani D, Petrosini L, Paludetti G. Cochlear injury and adaptive plasticity of the auditory cortex. Front Aging Neurosci. 2015;7:8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wang J, Puel J-L. Toward cochlear therapies. Physiol Rev. 2018;98:2477–522.

    Article  CAS  PubMed  Google Scholar 

  3. Kujawa SG, Liberman MC. Synaptopathy in the noise-exposed and aging cochlea: primary neural degeneration in acquired sensorineural hearing loss. Hear Res. 2015;330:191–9.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Muly S. Synaptophysin in the cochlear nucleus following acoustic trauma. Exp Neurol. 2002;177:202–21.

    Article  CAS  PubMed  Google Scholar 

  5. Kim JJ, Gross J, Potashner SJ, Morest DK. Fine structure of long-term changes in the cochlear nucleus after acoustic overstimulation: chronic degeneration and new growth of synaptic endings. J Neurosci Res. 2004;77:817–28.

    Article  CAS  PubMed  Google Scholar 

  6. Muly SM, Gross JS, Potashner SJ. Noise trauma altersD-[3H]aspartate release and AMPA binding in chinchilla cochlear nucleus. J Neurosci Res. 2004;75:585–96.

    Article  CAS  PubMed  Google Scholar 

  7. Fetoni AR, De Bartolo P, Eramo SLM, Rolesi R, Paciello F, Bergamini C, et al. Noise-induced hearing loss (NIHL) as a target of oxidative stress-mediated damage: cochlear and cortical responses after an increase in antioxidant defense. J Neurosci. 2013;33:4011–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Paciello F, Podda MV, Rolesi R, Cocco S, Petrosini L, Troiani D, et al. Anodal transcranial direct current stimulation affects auditory cortex plasticity in normal-hearing and noise-exposed rats. Brain Stimul. 2018;11:1008–23.

    Article  PubMed  Google Scholar 

  9. Paciello F, Rinaudo M, Longo V, Cocco S, Conforto G, Pisani A, et al. Auditory sensory deprivation induced by noise exposure exacerbates cognitive decline in a mouse model of Alzheimer’s disease. Elife. 2021;10:e70908.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Paciello F, Pisani A, Rinaudo M, Cocco S, Paludetti G, Fetoni AR, et al. Noise-induced auditory damage affects hippocampus causing memory deficits in a model of early age-related hearing loss. Neurobiol Dis. 2023;178: 106024.

    Article  PubMed  Google Scholar 

  11. Wakabayashi K, Fujioka M, Kanzaki S, Okano HJ, Shibata S, Yamashita D, et al. Blockade of interleukin-6 signaling suppressed cochlear inflammatory response and improved hearing impairment in noise-damaged mice cochlea. Neurosci Res. 2010;66:345–52.

    Article  CAS  PubMed  Google Scholar 

  12. Tan WJT, Thorne PR, Vlajkovic SM. Characterisation of cochlear inflammation in mice following acute and chronic noise exposure. Histochem Cell Biol. 2016;146:219–30.

    Article  CAS  PubMed  Google Scholar 

  13. Benkafadar N, Menardo J, Bourien J, Nouvian R, François F, Decaudin D, et al. Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy. EMBO Mol Med. 2017;9:7–26.

    Article  CAS  PubMed  Google Scholar 

  14. Shen Y, Hu H, Fan C, Wang Q, Zou T, Ye B, et al. Sensorineural hearing loss may lead to dementia-related pathological changes in hippocampal neurons. Neurobiol Dis. 2021;156: 105408.

    Article  CAS  PubMed  Google Scholar 

  15. Block ML, Zecca L, Hong J-S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci. 2007;8:57–69.

    Article  CAS  PubMed  Google Scholar 

  16. Lin M, Yu H, Xie Q, Xu Z, Shang P. Role of microglia autophagy and mitophagy in age-related neurodegenerative diseases. Front Aging Neurosci. 2023;14:1100133.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Fujikawa R, Tsuda M. The functions and phenotypes of microglia in Alzheimer’s disease. Cells. 2023;12:1207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Abe N, Nishihara T, Yorozuya T, Tanaka J. Microglia and macrophages in the pathological central and peripheral nervous systems. Cells. 2020;9:2132.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Morris G, Gevezova M, Sarafian V, Maes M. Redox regulation of the immune response. Cell Mol Immunol. 2022;19:1079–101.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Rasband MN. Glial contributions to neural function and disease. Mol Cell Proteomics. 2016;15:355–61.

    Article  CAS  PubMed  Google Scholar 

  21. Garland EF, Hartnell IJ, Boche D. Microglia and astrocyte function and communication: what do we know in humans? Front Neurosci. 2022;16: 824888.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Valles SL, Singh SK, Campos-Campos J, Colmena C, Campo-Palacio I, Alvarez-Gamez K, et al. Functions of astrocytes under normal conditions and after a brain disease. IJMS. 2023;24:8434.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Cuadros MA, Sepulveda MR, Martin-Oliva D, Marín-Teva JL, Neubrand VE. Microglia and microglia-like cells: similar but different. Front Cell Neurosci. 2022;16: 816439.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Miron VE, Priller J. Investigating microglia in health and disease: challenges and opportunities. Trends Immunol. 2020;41:785–93.

    Article  CAS  PubMed  Google Scholar 

  25. Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333:1456–8.

    Article  CAS  PubMed  Google Scholar 

  26. Schafer DP, Stevens B. Phagocytic glial cells: sculpting synaptic circuits in the developing nervous system. Curr Opin Neurobiol. 2013;23:1034–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Cramer KS, Rubel EW. Glial cell contributions to auditory brainstem development. Front Neural Circuits. 2016;10:83.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164–78.

    Article  CAS  PubMed  Google Scholar 

  29. Jurga AM, Paleczna M, Kuter KZ. Overview of general and discriminating markers of differential microglia phenotypes. Front Cell Neurosci. 2020;14:198.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Paolicelli RC, Sierra A, Stevens B, Tremblay M-E, Aguzzi A, Ajami B, et al. Microglia states and nomenclature: a field at its crossroads. Neuron. 2022;110:3458–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Huang H, He W, Tang T, Qiu M. Immunological markers for central nervous system glia. Neurosci Bull. 2023;39:379–92.

    Article  PubMed  Google Scholar 

  32. Butovsky O, Weiner HL. Microglial signatures and their role in health and disease. Nat Rev Neurosci. 2018;19:622–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Li Q, Barres BA. Microglia and macrophages in brain homeostasis and disease. Nat Rev Immunol. 2018;18:225–42.

    Article  CAS  PubMed  Google Scholar 

  34. Borst K, Dumas AA, Prinz M. Microglia: immune and non-immune functions. Immunity. 2021;54:2194–208.

    Article  CAS  PubMed  Google Scholar 

  35. Davies LC, Taylor PR. Tissue-resident macrophages: then and now. Immunology. 2015;144:541–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Keithley EM. Inner ear immunity. Hear Res. 2022;419: 108518.

    Article  PubMed  Google Scholar 

  37. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Hough K, Verschuur CA, Cunningham C, Newman TA. Macrophages in the cochlea; an immunological link between risk factors and progressive hearing loss. Glia. 2022;70:219–38.

    Article  CAS  PubMed  Google Scholar 

  39. Alliot F, Godin I, Pessac B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Dev Brain Res. 1999;117:145–52.

    Article  CAS  Google Scholar 

  40. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330:841–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Katsumoto A, Lu H, Miranda AS, Ransohoff RM. Ontogeny and functions of central nervous system macrophages. J Immunol. 2014;193:2615–21.

    Article  CAS  PubMed  Google Scholar 

  42. Hirose K, Discolo CM, Keasler JR, Ransohoff R. Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma. J Comparative Neurol. 2005;489:180–94.

    Article  Google Scholar 

  43. Parisi L, Gini E, Baci D, Tremolati M, Fanuli M, Bassani B, et al. Macrophage polarization in chronic inflammatory diseases: killers or builders? J Immunol Res. 2018;2018:1–25.

    Article  Google Scholar 

  44. Spencer NG, Schilling T, Miralles F, Eder C. Mechanisms underlying interferon-γ-induced priming of microglial reactive oxygen species production. PLoS ONE. 2016;11:e0162497.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Simpson DSA, Oliver PL. ROS generation in microglia: understanding oxidative stress and inflammation in neurodegenerative disease. Antioxidants. 2020;9:743.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Smith AN, Shaughness M, Collier S, Hopkins D, Byrnes KR. Therapeutic targeting of microglia mediated oxidative stress after neurotrauma. Front Med. 2022;9:1034692.

    Article  Google Scholar 

  47. Loane DJ, Kumar A. Microglia in the TBI brain: the good, the bad, and the dysregulated. Exp Neurol. 2016;275:316–27.

    Article  CAS  PubMed  Google Scholar 

  48. Członkowska A, Kurkowska-Jastrzębska I, Członkowski A, Peter D, Stefano GB. Immune processes in the pathogenesis of Parkinson’s disease – a potential role for microglia and nitric oxide. Med Sci Monit. 2002;8:165–77.

    Google Scholar 

  49. Eugenín EA, Eckardt D, Theis M, Willecke K, Bennett MVL, Sáez JC. Microglia at brain stab wounds express connexin 43 and in vitro form functional gap junctions after treatment with interferon-γ and tumor necrosis factor-α. Proc Natl Acad Sci USA. 2001;98:4190–5.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Retamal MA, Cortés CJ, Reuss L, Bennett MVL, Sáez JC. S-nitrosylation and permeation through connexin 43 hemichannels in astrocytes: induction by oxidant stress and reversal by reducing agents. Proc Natl Acad Sci USA. 2006;103:4475–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Gajardo-Gómez R, Labra VC, Orellana JA. Connexins and pannexins: new insights into microglial functions and dysfunctions. Front Mol Neurosci. 2016;6:9.

    Google Scholar 

  52. Seo JH, Dalal MS, Contreras JE. Pannexin-1 channels as mediators of neuroinflammation. IJMS. 2021;22:5189.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Caruso G, Di Pietro L, Caraci F. Gap junctions and connexins in microglia-related oxidative stress and neuroinflammation: perspectives for drug discovery. Biomolecules. 2023;13:505.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  54. Suadicani SO, Brosnan CF, Scemes E. P2X 7 receptors mediate ATP release and amplification of astrocytic intercellular Ca 2+ signaling. J Neurosci. 2006;26:1378–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Scemes E, Suadicani SO, Dahl G, Spray DC. Connexin and pannexin mediated cell–cell communication. Neuron Glia Biol. 2007;3:199–208.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Rouach N, Calvo C-F, Glowinski J, Giaume C. Brain macrophages inhibit gap junctional communication and downregulate connexin 43 expression in cultured astrocytes: brain macrophages and gap junctions in astrocytes. Eur J Neurosci. 2002;15:403–7.

    Article  CAS  PubMed  Google Scholar 

  57. Faustmann PM, Haase CG, Romberg S, Hinkerohe D, Szlachta D, Smikalla D, et al. Microglia activation influences dye coupling and Cx43 expression of the astrocytic network. Glia. 2003;42:101–8.

    Article  PubMed  Google Scholar 

  58. Hinkerohe D, Smikalla D, Haghikia A, Heupel K, Haase CG, Dermietzel R, et al. Effects of cytokines on microglial phenotypes and astroglial coupling in an inflammatory coculture model. Glia. 2005;52:85–97.

    Article  PubMed  Google Scholar 

  59. Même W, Calvo C, Froger N, Ezan P, Amigou E, Koulakoff A, et al. Proinflammatory cytokines released from microglia inhibit gap junctions in astrocytes: potentiation by β-amyloid. FASEB j. 2006;20:494–6.

    Article  PubMed  Google Scholar 

  60. Retamal MA, Froger N, Palacios-Prado N, Ezan P, Sáez PJ, Sáez JC, et al. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci. 2007;27:13781–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Orellana JA, Froger N, Ezan P, Jiang JX, Bennett MVL, Naus CC, et al. ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels: astroglial hemichannels induce neuronal death. J Neurochem. 2011;118:826–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Fuentes-Santamaría V, Alvarado JC, Juiz JM. Long-term interaction between microglial cells and cochlear nucleus neurons after bilateral cochlear ablation. J Comp Neurol. 2012;520:2974–90.

    Article  PubMed  Google Scholar 

  63. Baizer JS, Wong KM, Manohar S, Hayes SH, Ding D, Dingman R, et al. Effects of acoustic trauma on the auditory system of the rat: the role of microglia. Neuroscience. 2015;303:299–311.

    Article  CAS  PubMed  Google Scholar 

  64. Campos Torres A, Vidal PP, de Waele C. Evidence for a microglial reaction within the vestibular and cochlear nuclei following inner ear lesion in the rat. Neuroscience. 1999;92:1475–90.

    Article  CAS  PubMed  Google Scholar 

  65. Noda M, Hatano M, Hattori T, Takarada-Iemata M, Shinozaki T, Sugimoto H, et al. Microglial activation in the cochlear nucleus after early hearing loss in rats. Auris Nasus Larynx. 2019;46:716–23.

    Article  PubMed  Google Scholar 

  66. Fetoni AR, Paciello F, Rolesi R, Pisani A, Moleti A, Sisto R, et al. Styrene targets sensory and neural cochlear function through the crossroad between oxidative stress and inflammation. Free Radical Biol Med. 2021;163:31–42.

    Article  CAS  Google Scholar 

  67. Fetoni AR, Rolesi R, Paciello F, Eramo SLM, Grassi C, Troiani D, et al. Styrene enhances the noise induced oxidative stress in the cochlea and affects differently mechanosensory and supporting cells. Free Radical Biol Med. 2016;101:211–25.

    Article  CAS  Google Scholar 

  68. Sisto R, Cerini L, Gatto MP, Gherardi M, Gordiani A, Sanjust F, et al. Otoacoustic emission sensitivity to exposure to styrene and noise. J Acoust Soc Am. 2013;134:3739–48.

    Article  CAS  PubMed  Google Scholar 

  69. Chen G-D, Henderson D. Cochlear injuries induced by the combined exposure to noise and styrene. Hear Res. 2009;254:25–33.

    Article  CAS  PubMed  Google Scholar 

  70. Alvarado JC, Fuentes-Santamaría V, Jareño-Flores T, Blanco JL, Juiz JM. Normal variations in the morphology of auditory brainstem response (ABR) waveforms: a study in wistar rats. Neurosci Res. 2012;73:302–11.

    Article  PubMed  Google Scholar 

  71. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates, 2. San Diego: Academic; 2001.

    Google Scholar 

  72. Eng LF, Ghirnikar RS. GFAP and astrogliosis. Brain Pathol. 1994;4:229–37.

    Article  CAS  PubMed  Google Scholar 

  73. Hol EM, Pekny M. Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. Curr Opin Cell Biol. 2015;32:121–30.

    Article  CAS  PubMed  Google Scholar 

  74. Korzhevskii DE, Kirik OV. Brain microglia and microglial markers. Neurosci Behav Physi. 2016;46:284–90.

    Article  CAS  Google Scholar 

  75. Sholl DA. The measurable parameters of the cerebral cortex and their significance in its organization. Prog Neurobiol. 1956;2:324e33.

    Google Scholar 

  76. Bisicchia E, Sasso V, Catanzaro G, Leuti A, Besharat ZM, Chiacchiarini M, et al. Resolvin D1 halts remote neuroinflammation and improves functional recovery after focal brain damage via ALX/FPR2 receptor-regulated MicroRNAs. Mol Neurobiol. 2018;55:6894–905.

    Article  CAS  PubMed  Google Scholar 

  77. Kongsui R, Beynon SB, Johnson SJ, Walker FR. Quantitative assessment of microglial morphology and density reveals remarkable consistency in the distribution and morphology of cells within the healthy prefrontal cortex of the rat. J Neuroinflammation. 2014;11:182.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Catale C, Bisicchia E, Carola V, Viscomi MT. Early life stress exposure worsens adult remote microglia activation, neuronal death, and functional recovery after focal brain injury. Brain Behav Immun. 2021;94:89–103.

    Article  PubMed  Google Scholar 

  79. Fetoni AR, Pisani A, Rolesi R, Paciello F, Viziano A, Moleti A, et al. Early noise-induced hearing loss accelerates presbycusis altering aging processes in the cochlea. Front Aging Neurosci. 2022;14: 803973.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  80. Fetoni AR, Eramo SLM, Paciello F, Rolesi R, Samengo D, Paludetti G, et al. The redox protein p66shc mediates cochlear vascular dysfunction and transient noise-induced hearing loss. Sci Rep. 2016;6:25450.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Havekes R, Timmer M, Van der Zee EA. Regional differences in hippocampal PKA immunoreactivity after training and reversal training in a spatial Y-maze task. Hippocampus. 2007;17:338–48.

    Article  CAS  PubMed  Google Scholar 

  82. Man H-Y, Sekine-Aizawa Y, Huganir RL. Regulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking through PKA phosphorylation of the Glu receptor 1 subunit. Proc Natl Acad Sci USA. 2007;104:3579–84.

    Article  PubMed  PubMed Central  Google Scholar 

  83. He K, Song L, Cummings LW, Goldman J, Huganir RL, Lee H-K. Stabilization of Ca 2+ -permeable AMPA receptors at perisynaptic sites by GluR1-S845 phosphorylation. Proc Natl Acad Sci USA. 2009;106:20033–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  84. Goel A, Xu LW, Snyder KP, Song L, Goenaga-Vazquez Y, Megill A, et al. Phosphorylation of AMPA receptors is required for sensory deprivation-induced homeostatic synaptic plasticity. PLoS ONE. 2011;6:e18264.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Chen G-D, Chi L-H, Kostyniak PJ, Henderson D. Styrene induced alterations in biomarkers of exposure and effects in the cochlea: mechanisms of hearing loss. Toxicol Sci. 2007;98:167–77.

    Article  CAS  PubMed  Google Scholar 

  86. Vane JR, Bakhle YS, Botting R. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97–120.

    Article  CAS  PubMed  Google Scholar 

  87. Jones SA, Wolf M, Qin S, Mackay CR, Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA. 1996;93:6682–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Cambier S, Gouwy M, Proost P. The chemokines CXCL8 and CXCL12: molecular and functional properties, role in disease and efforts towards pharmacological intervention. Cell Mol Immunol. 2023;20:217–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Rio C, Dikkes P, Liberman MC, Corfas G. Glial fibrillary acidic protein expression and promoter activity in the inner ear of developing and adult mice. J Comp Neurol. 2002;442:156–62.

    Article  CAS  PubMed  Google Scholar 

  90. Salter MW, Stevens B. Microglia emerge as central players in brain disease. Nat Med. 2017;23:1018–27.

    Article  CAS  PubMed  Google Scholar 

  91. Mammano F. Inner ear connexin channels: roles in development and maintenance of cochlear function. Cold Spring Harb Perspect Med. 2019;9: a033233.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Paciello F, Zorzi V, Raspa M, Scavizzi F, Grassi C, Mammano F, et al. Connexin 30 deletion exacerbates cochlear senescence and age-related hearing loss. Front Cell Dev Biol. 2022;10: 950837.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Kessels HW, Kopec CD, Klein ME, Malinow R. Roles of stargazin and phosphorylation in the control of AMPA receptor subcellular distribution. Nat Neurosci. 2009;12:888–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Morgan MJ, Liu Z. Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 2011;21:103–15.

    Article  CAS  PubMed  Google Scholar 

  95. Blaser H, Dostert C, Mak TW, Brenner D. TNF and ROS Crosstalk in Inflammation. Trends Cell Biol. 2016;26:249–61.

    Article  CAS  PubMed  Google Scholar 

  96. Kalinec GM, Lomberk G, Urrutia RA, Kalinec F. Resolution of cochlear inflammation: novel target for preventing or ameliorating drug-, noise- and age-related hearing loss. Front Cell Neurosci. 2017;11:192.

    Article  PubMed  PubMed Central  Google Scholar 

  97. Fetoni AR, Paciello F, Rolesi R, Paludetti G, Troiani D. Targeting dysregulation of redox homeostasis in noise-induced hearing loss: oxidative stress and ROS signaling. Free Radical Biol Med. 2019;135:46–59.

    Article  CAS  Google Scholar 

  98. Daré E, Tofighi R, Nutt L, Vettori MV, Emgård M, Mutti A, et al. Styrene 7,8-oxide induces mitochondrial damage and oxidative stress in neurons. Toxicology. 2004;201:125–32.

    Article  PubMed  Google Scholar 

  99. Vettori MV, Caglieri A, Goldoni M, Castoldi AF, Darè E, Alinovi R, et al. Analysis of oxidative stress in SK-N-MC neurons exposed to styrene-7,8-oxide. Toxicol In Vitro. 2005;19:11–20.

    Article  CAS  PubMed  Google Scholar 

  100. Meszka-Jordan A, Mahlapuu R, Soomets U, Carlson GP. Oxidative stress due to (R)-styrene oxide exposure and the role of antioxidants in non-Swiss albino (NSA) mice. J Toxicol Environ Health A. 2009;72:642–50.

    Article  CAS  PubMed  Google Scholar 

  101. Sisto R, Botti T, Cerini L, Sanjust F, Tranfo G, Bonanni RC, et al. Oxidative stress biomarkers and otoacoustic emissions in humans exposed to styrene and noise. Int J Audiol. 2016;55:523–31.

    Article  CAS  PubMed  Google Scholar 

  102. Fuentes-Santamaría V, Alvarado JC, Melgar-Rojas P, Gabaldón-Ull MC, Miller JM, Juiz JM. The role of glia in the peripheral and central auditory system following noise overexposure: contribution of TNF-α and IL-1β to the pathogenesis of hearing loss. Front Neuroanat. 2017;11:9.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Wang Z, Li H. Microglia-like cells in rat organ of corti following aminoglycoside ototoxicity. NeuroReport. 2000;11:1389–93.

    Article  CAS  PubMed  Google Scholar 

  104. Ladrech S, Wang J, Simonneau L, Puel J-L, Lenoir M. Macrophage contribution to the response of the rat organ of Corti to amikacin. J Neurosci Res. 2007;85:1970–9.

    Article  CAS  PubMed  Google Scholar 

  105. Noble K, Brown L, Elvis P, Lang H. Cochlear immune response in presbyacusis: a focus on dysregulation of macrophage activity. JARO. 2022;23:1–16.

    Article  PubMed  Google Scholar 

  106. Kaur T, Ohlemiller KK, Warchol ME. Genetic disruption of fractalkine signaling leads to enhanced loss of cochlear afferents following ototoxic or acoustic injury. J Comp Neurol. 2018;526:824–35.

    Article  CAS  PubMed  Google Scholar 

  107. Colton CA. Heterogeneity of microglial activation in the innate immune response in the brain. J Neuroimmune Pharmacol. 2009;4:399–418.

    Article  PubMed  PubMed Central  Google Scholar 

  108. Garden GA, Möller T. Microglia biology in health and disease. Jrnl NeuroImmune Pharm. 2006;1:127–37.

    Article  Google Scholar 

  109. Saijo K, Glass CK. Microglial cell origin and phenotypes in health and disease. Nat Rev Immunol. 2011;11:775–87.

    Article  CAS  PubMed  Google Scholar 

  110. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87:315–424.

    Article  CAS  PubMed  Google Scholar 

  111. Brown GC, Neher JJ. Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol. 2010;41:242–7.

    Article  CAS  PubMed  Google Scholar 

  112. Saha RN, Pahan K. Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal. 2006;8:929–47.

    Article  CAS  PubMed  Google Scholar 

  113. Minghetti L, Nicolini A, Polazzi E, Créminon C, Maclouf J, Levi G. Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors. Glia. 1997;19:152–60.

    Article  CAS  PubMed  Google Scholar 

  114. Kempermann G, Neumann H. Microglia: the enemy within? Science. 2003;302:1689–90.

    Article  CAS  PubMed  Google Scholar 

  115. Graeber MB, Li W, Rodriguez ML. Role of microglia in CNS inflammation. FEBS Lett. 2011;585:3798–805.

    Article  CAS  PubMed  Google Scholar 

  116. Muzio L, Viotti A, Martino G. Microglia in neuroinflammation and neurodegeneration: from understanding to therapy. Front Neurosci. 2021;15: 742065.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Mander P, Brown GC. Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration. J Neuroinflammation. 2005;2:20.

    Article  PubMed  PubMed Central  Google Scholar 

  118. Ogura T, Tatemichi M, Esumi H. TNF-a mediates inducible nitric oxide synthase expression in human neuroblastoma cell line by cisplatin. Biochem Biophys Res Commun. 1997;233:788–91.

    Article  CAS  PubMed  Google Scholar 

  119. Heneka MT, Löschmann P-A, Gleichmann M, Weller M, Schulz JB, Wüllner U, et al. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-α/lipopolysaccharide. J Neurochem. 2002;71:88–94.

    Article  Google Scholar 

  120. Combs CK, Karlo JC, Kao S-C, Landreth GE. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J Neurosci. 2001;21:1179–88.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  121. Flynn G, Maru S, Loughlin J, Romero IA, Male D. Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol. 2003;136:84–93.

    Article  CAS  PubMed  Google Scholar 

  122. Madore C, Joffre C, Delpech JC, De Smedt-Peyrusse V, Aubert A, Coste L, et al. Early morphofunctional plasticity of microglia in response to acute lipopolysaccharide. Brain Behav Immun. 2013;34:151–8.

    Article  CAS  PubMed  Google Scholar 

  123. Sierra A, Abiega O, Shahraz A, Neumann H. Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis. Front Cell Neurosci 2013;7.

  124. Waller R, Baxter L, Fillingham DJ, Coelho S, Pozo JM, Mozumder M, et al. Iba-1-/CD68+ microglia are a prominent feature of age-associated deep subcortical white matter lesions. PLoS ONE. 2019;14:e0210888.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. Yang Z, Wang KKW. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015;38:364–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Wilhelmsson U, Bushong EA, Price DL, Smarr BL, Phung V, Terada M, et al. Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci USA. 2006;103:17513–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Wilhelmsson U, Li L, Pekna M, Berthold C-H, Blom S, Eliasson C, et al. Absence of glial fibrillary acidic protein and vimentin prevents hypertrophy of astrocytic processes and improves post-traumatic regeneration. J Neurosci. 2004;24:5016–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  128. Garg S, Syed MM, Kielian T. Staphylococcus aureus-derived peptidoglycan induces Cx43 expression and functional gap junction intercellular communication in microglia. J Neurochem. 2005;95:475–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  129. Sáez PJ, Shoji KF, Retamal MA, Harcha PA, Ramírez G, Jiang JX, et al. ATP is required and advances cytokine-induced gap junction formation in microglia in vitro. Mediators Inflamm. 2013;2013:1–16.

    Article  Google Scholar 

  130. Giaume C, Fromaget C, el Aoumari A, Cordier J, Glowinski J, Gros D. Gap junctions in cultured astrocytes: single-channel currents and characterization of channel-forming protein. Neuron. 1991;6:133–43.

    Article  CAS  PubMed  Google Scholar 

  131. Zhang J, Riquelme MA, Hua R, Acosta FM, Gu S, Jiang JX. Connexin 43 hemichannels regulate mitochondrial ATP generation, mobilization, and mitochondrial homeostasis against oxidative stress. Elife. 2022;11:e82206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  132. Orellana JA, Shoji KF, Abudara V, Ezan P, Amigou E, Sáez PJ, et al. Amyloid β-induced death in neurons involves glial and neuronal hemichannels. J Neurosci. 2011;31:4962–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Li Y, Du X, Du J. Resting microglia respond to and regulate neuronal activity in vivo. Commun Integr Biol. 2013;6:e24493.

    Article  PubMed  PubMed Central  Google Scholar 

  134. Verselis VK. Connexin hemichannels and cochlear function. Neurosci Lett. 2019;695:40–5.

    Article  CAS  PubMed  Google Scholar 

  135. Snoeckx RL, Huygen PLM, Feldmann D, Marlin S, Denoyelle F, Waligora J, et al. GJB2 mutations and degree of hearing loss: a multicenter study. Am J Human Genet. 2005;77:945–57.

    Article  CAS  Google Scholar 

  136. Kenna MA, Feldman HA, Neault MW, Frangulov A, Wu B-L, Fligor B, et al. Audiologic phenotype and progression in GJB2 (Connexin 26) hearing loss. Arch Otolaryngol Head Neck Surg. 2010;136:81.

    Article  PubMed  PubMed Central  Google Scholar 

  137. del Castillo FJ, del Castillo I. DFNB1 non-syndromic hearing impairment: diversity of mutations and associated phenotypes. Front Mol Neurosci. 2017;10:428.

    Article  PubMed  PubMed Central  Google Scholar 

  138. Tajima S, Danzaki K, Ikeda K, Kamiya K. Degradation and modification of cochlear gap junction proteins in the early development of age-related hearing loss. Exp Mol Med. 2020;52:166–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  139. Ichimiya I, Suzuki M, Mogi G. Age-related changes in the murine cochlear lateral wall. Hear Res. 2000;139:116–22.

    Article  CAS  PubMed  Google Scholar 

  140. Fetoni AR, Zorzi V, Paciello F, Ziraldo G, Peres C, Raspa M, et al. Cx26 partial loss causes accelerated presbycusis by redox imbalance and dysregulation of Nfr2 pathway. Redox Biol. 2018;19:301–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  141. Zhao H-B, Zhu Y, Liang C, Chen J. Pannexin 1 deficiency can induce hearing loss. Biochem Biophys Res Commun. 2015;463:143–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  142. Chen J, Liang C, Zong L, Zhu Y, Zhao H-B. Knockout of pannexin-1 induces hearing loss. IJMS. 2018;19:1332.

    Article  PubMed  PubMed Central  Google Scholar 

  143. Abitbol JM, Kelly JJ, Barr K, Schormans AL, Laird DW, Allman BL. Differential effects of pannexins on noise-induced hearing loss. Biochem J. 2016;473:4665–80.

    Article  CAS  PubMed  Google Scholar 

  144. Zorzi V, Paciello F, Ziraldo G, Peres C, Mazzarda F, Nardin C, et al. Mouse Panx1 is dispensable for hearing acquisition and auditory function. Front Mol Neurosci. 2017;10:379.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We would like to acknowledge the contribution of "Microscopy" Core Facility G-STeP and the contribution of the Core Facility G-STeP "Electrophysiology", Fondazione Policlinico Universitario “A. Gemelli” IRCCS.

Funding

This work was supported by “Fondi BRIC INAIL 2022”. Università Cattolica del Sacro Cuore contributed to the funding of this research project and its publication (D1, D3.1 intramural funds). Financial support of “Ricerca Corrente 2023” from Fondazione Policlinico Universitario “A. Gemelli” IRCCS to C.G.

Author information

Authors and Affiliations

  1. Department of Neuroscience, Università Cattolica del Sacro Cuore, 00168, Rome, Italy

    Fabiola Paciello, Giammarco Boni, Cristian Ripoli & Claudio Grassi

  2. Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Rome, Italy

    Fabiola Paciello, Rolando Rolesi, Cristian Ripoli, Jacopo Galli & Claudio Grassi

  3. Department of Head and Neck Surgery, Università Cattolica del Sacro Cuore, Rome, Italy

    Anna Pisani, Rolando Rolesi, Raffaele Montuoro, Veronica Mohamed-Hizam & Jacopo Galli

  4. Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, Italian Workers’ Compensation Authority (INAIL), Monte Porzio Catone, Rome, Italy

    Renata Sisto

  5. Department of Neuroscience, Unit of Audiology, Università Degli Studi di Napoli Federico II, Naples, Italy

    Anna Rita Fetoni

Authors
  1. Fabiola Paciello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Pisani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rolando Rolesi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raffaele Montuoro
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Veronica Mohamed-Hizam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giammarco Boni
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Cristian Ripoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jacopo Galli
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Renata Sisto
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Anna Rita Fetoni
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Claudio Grassi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

FP: formal analysis, investigation, data curation, conceptualization, writing—original draft preparation; AP, RM, VMH, GB: formal analysis, investigation, data curation; RR: formal analysis; CR: validation, data curation; RS: validation, data curation; ARF: supervision; funding acquisition; CG: conceptualization, supervision, writing—review and editing, funding acquisition.

Corresponding author

Correspondence to Anna Rita Fetoni.

Ethics declarations

Ethics approval and consent to participate

All efforts were made to minimize animal suffering and number, in agreement with the European Community Council Directive of 24 November 1986(86/609/EEC). All procedures were performed in accordance with the Laboratory of Animal Care and Use Committee of the Catholic University, School of Medicine of Rome and were approved by the Italian Department of Health (Ministero della Salute, Prot. 1F295.116).

Competing interests

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Supplementary Table 1: List of abbreviations.

Additional file 2.

Arrive guidelines.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paciello, F., Pisani, A., Rolesi, R. et al. Oxidative stress and inflammation cause auditory system damage via glial cell activation and dysregulated expression of gap junction proteins in an experimental model of styrene-induced oto/neurotoxicity. J Neuroinflammation 21, 4 (2024). https://doi.org/10.1186/s12974-023-02996-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12974-023-02996-3

Keywords

Journal of Neuroinflammation

ISSN: 1742-2094